Navigation Links
Searcy Denney Scarola Barnhart & Shipley PA Seeks Damages Caused by Recalled Product

WEST PALM BEACH, Fla., Aug. 8, 2012 /PRNewswire/ -- South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA (Searcy Denney) announced today that it has filed the first lawsuit against Howmedica Osteonics Corporation, dba Stryker Orthopaedics, claiming damages caused by the company's defective and recalled Rejuvenate and ABG II hip implant systems.

The suit was filed in Bergen County, New Jersey Superior Court, by Searcy Denney and Weitz & Luxenberg on behalf of plaintiffs Dianne and Phillip Pingel. The plaintiffs allege that the defendant was negligent and failed to use reasonable care for the safety and well-being of patients in the development, testing, marketing, packaging, and selling of the defective product.

On July 4, 2012, Stryker posted a national recall of the Rejuvenate and ABG II hip implant systems apparently after receiving multiple reports of the premature failure of those implants. "That recall is tantamount to an unequivocal admission by the defendant as to the dangers and defects of their product," said Cal Warriner, a shareholder at Searcy Denney, who represents Mr. and Mrs. Pingel. "Stryker must now redress the damages that these defective systems have caused."

The lawsuit seeks compensatory and punitive damages to cover the medical, hospital, rehabilitation, and pharmaceutical costs incurred by the plaintiffs as a direct result of the implant failures.

"Currently there are more than 60 adverse event reports filed with the FDA's MAUDE incident reporting system," Warriner added. "The Rejuvenate device has been on the market since 2009 and the number of incidents has been climbing exponentially since the beginning of 2012.

"These devices are supposed to last 15 to 20 years. When they fail in huge numbers in less than two years post-implant, there is a serious problem."

Dianne Pingel had the misfortune of being implanted with two defective Stryker Rejuvenate hip implants. One of the implants failed, due to heavy metal ion contamination and poisoning caused by fretting and corrosion. During her revision surgery, her femur fractured.  Four weeks later, her hip dislocated and her femur fractured again. She has undergone a third surgery recently and is currently confined to a nursing home. In the future, she will need to undergo additional surgery to remove the defective Rejuvenate implant from her other hip. Her recovery has been complicated by pseudotumor formation, bone necrosis, and adverse soft tissue reactions relating to the implant corrosion.

Stryker hip implants have been a particular source of controversy since April 2012, when Howmedica Osteonics issued an Urgent Field Safety Notice to surgeons and hospitals that cited failures at the taper neck junction causing corrosion and fretting. The defendant had previously claimed that these problems would not occur due to the new design of the system. 

The plaintiffs have requested a jury trial.

About Searcy Denney Scarola Barnhart & Shipley, PA

A nationally recognized trial law firm, Searcy Denney Scarola Barnhart & Shipley, P.A. is committed to protecting victims of negligence, defective products and corporate wrongdoing.  Over the past 30 years, the firm has represented clients in courtrooms throughout Florida and across the nation.

SOURCE Searcy Denney Scarola Barnhart & Shipley PA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Increasing Minimal Invasive Surgeries to Boost Adoption of Hybrid Operating Rooms in Europe, Says Frost & Sullivan
2. Positron Consolidates Radiopharmaceutical & Radioisotope Facilities
3. Japanese Market for Orthopedic Soft Tissue Repair & Sports Medicine
4. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
5. Riordan Lewis & Haden
6. Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion
7. Law Office of Brodsky & Smith, LLC Announces Settlements of Yaz, and Yasmin Cases
8. Frost & Sullivan: Improving Economies in Indonesia and Vietnam Present Strong Growth Potential in Healthcare
9. Austin Recovery Becomes Learning Environment for Texas A&M Health Science Center Medical Students
10. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
11. Vaginal Mesh Lawsuits Pick Up Momentum, According To Pulaski & Middleman, LLC
Post Your Comments:
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
Breaking Medicine News(10 mins):